Revolution of Helicobacter pylori treatment

Author:

Yamaoka Yoshio1234ORCID

Affiliation:

1. Department of Environmental and Preventive Medicine Oita University Faculty of Medicine Yufu Japan

2. The Research Center for GLOBAL and LOCAL Infectious Diseases (RCGLID) Oita University Yufu Japan

3. Department of Medicine, Gastroenterology and Hepatology Section Baylor College of Medicine Houston Texas USA

4. Division of Gastroentero‐Hepatology, Department of Internal Medicine, Faculty of Medicine‐Dr. Soetomo Teaching Hospital Universitas Airlangga Surabaya Indonesia

Abstract

AbstractHelicobacter pylori infection is a major global health concern, and its management has witnessed a revolutionary shift with the emergence of antibiotic resistance. In this review, I explore the mechanisms of H. pylori antibiotic resistance and highlight the critical need for susceptibility‐based eradication treatments. The increasing prevalence of antibiotic‐resistant strains requires innovative approaches to combat this resilient pathogen. I also delve into the importance of mass screening as a preventive strategy for early detection and intervention, describing my experience in Bhutan. Additionally, I explore promising alternatives, such as vaccination. The aim of this review is to provide insight into the evolving landscape of H. pylori treatment and highlight the need for a paradigm shift in the approach to combating this persistent bacterial infection.

Funder

National Institutes of Health

Japan Agency for Medical Research and Development

Japan International Cooperation Agency

Publisher

Wiley

Reference69 articles.

1. Schistosomes, liver flukes and Helicobacter pylori;IARC Monogr. Eval. Carcinog. Risks Hum.,1994

2. Helicobacter pyloriInfection and the Development of Gastric Cancer

3. Helicobacter pylori infection and the risk of gastric malignancy;Hsu P‐I;Am. College Gastroenterol.|ACG,2007

4. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan

5. Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3